Inhibition of TLX expression significantly inhibited tumor growth and promoted antitumor immune responses by decreasing PD‐L1 expression, glioma‐associated macrophage numbers, and increasing cytotoxic lymphocyte infiltration. This evidence concerns the gene CD274 and neoplasm.